10.16.2018 Issue 423

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

Trump Signs Bills Banning Gag Clauses

Thursday, October 11

President Donald Trump on Wednesday signed into law two pieces of bipartisan legislation that outlaw pharmacy gag clauses, Fierce Healthcare reports.

A Look at the Evolving Health Market in the EU

Partnership of Hospitals Targets High Drug Prices

Researcher Reflects on 6 Years in Science

AJMC Set to Host Institute for Value-Based Medicine Meeting

Merck CEO Criticizes Middlemen in Supply Chain

Report: Staffing Shortages Trouble Managed Care Payers, State Medicaid Agencies

Visante Rolls Out Thought Leadership Series

Do Payers Really Want Pay-for-Performance?

Patients for Affordable Drugs Honors Former CMS Administrator Slavitt, Patient Advocate Hall

Research Data Assistant or Research Data Coordinator-PS8373

Research Associate III- Patient-Centered Research- Hammersmith

Healthcare Software Product Manager

Health Economist

Lead Health Economist

Associate Director Health Economics

Associate Director Real World Evidence (RWE) and Epidemiology

Associate Director/ Director, Medical Affairs- HEOR

Industry Spotlight

Conferences Webinars
3rd Annual Value-Based Care Summit
    October 17-19, Boston Massachusetts

Basket and Umbrella Trials for Clinical Oncology
    October 17-18, Philadelphia, Pennsylvania

ESMO 2018 Congress
    October 19-23, Munich, Germany

ISPOR Summit 2018
    October 19, Washington, D.C.

MAPS EMEA 2018 Meeting
    October 21-23, Berlin, Germany

Starting a Serious Conversation About Health Care Spending: What can we Learn From the Past and From Elsewhere?
    October 18

Outcomes-based Contracting Update: October Industry Trends Survey Results
    October 18

Extrapolation in Survival Analysis: What? Why? How? Where Next?
    October 22

How to Use the Immunization Delivery Cost Catalogue
    October 30

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs, Biologics

Blockchain: Transformational Change for Pharma?

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

HTA in Europe: Key Success Factors for Positive HTA Recommendations

Paying for Digital Health: Payer Insights

Health Care USA: A Cancer on the American Dream

The Utility of ICER Reports for Private Payer Drug Coverage Decision-Making: Cost-Effectiveness Assessments

Advancing Biosimilar Sustainability in Europe

A Holistic Approach to Payment Accuracy Helps Drive Cost Savings

Improving Patient Matching with a Simple Plug-In

Real-World Evidence in the Cloud: How Technology is Revealing the Big Picture in Pharma

How Payers Can Save an Average of $25,579 Per Patient by Eliminating Unwarranted, Non-Evidence-Based Cancer Treatment

Special Thanks to Our Partners:
            Evidera   HealthCore     University of FL  Xcenda
        OM1Parexel   Jefferson   Dymaxium   Precision Xtract
          Pharmerit    eMax Health   SciformixEvidence Partners
          ICON    Truven